AVEFF (Avecho Biotechnology) FCF Margin %: -501.76% (As of Dec. 2025)


What is Avecho Biotechnology FCF Margin %?

Avecho Biotechnology AVEFF -74.14% FCF Margin % is -501.76% as of Dec. 2025. The stock has 2 warning signs investors should review. Among 949 Biotechnology companies, Avecho Biotechnology ranks better than 98.42% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Avecho Biotechnology's Free Cash Flow for the six months ended in Dec. 2025 was $-2.28 Mil. Avecho Biotechnology's Revenue for the six months ended in Dec. 2025 was $0.45 Mil. Therefore, Avecho Biotechnology's FCF Margin % for the quarter that ended in Dec. 2025 was -501.76%.

As of today, Avecho Biotechnology's current FCF Yield % is 1.24%.

The historical rank and industry rank for Avecho Biotechnology's FCF Margin % or its related term are showing as below:

AVEFF' s FCF Margin % Range Over the Past 10 Years
Min: -670.89   Med: -360.74   Max: 88.59
Current: 82.07

During the past 13 years, the highest FCF Margin % of Avecho Biotechnology was 88.59%. The lowest was -670.89%. And the median was -360.74%.

AVEFF's FCF Margin % is ranked better than
98.42% of 949 companies
in the Biotechnology industry
Industry Median: -82.65 vs AVEFF: 82.07

Avecho Biotechnology FCF Margin % Related Terms

Avecho Biotechnology FCF Margin % Historical Data

* Premium members only.

The historical data trend for Avecho Biotechnology's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Avecho Biotechnology FCF Margin % Chart

Avecho Biotechnology Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
FCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -415.85 -142.38 -671.61 -350.14 88.63

Avecho Biotechnology Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -10,338.89 -133.23 -504.77 806.28 -501.76

AVEFF vs VRTX, REGN, ALNY: FCF Margin % Comparison

For the Biotechnology subindustry, Avecho Biotechnology's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Avecho Biotechnology FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Avecho Biotechnology's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Avecho Biotechnology's FCF Margin % falls into.


Avecho Biotechnology FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Avecho Biotechnology's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=0.733/0.827
=88.63 %

Avecho Biotechnology's FCF Margin for the quarter that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-2.278/0.454
=-501.76 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of -501.76% mean?
Avecho Biotechnology (AVEFF) has a FCF Margin % of -501.76% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Avecho Biotechnology and its competitors. According to the industry distribution chart, Avecho Biotechnology ranks #15 out of 949 companies in the Biotechnology industry, placing it in the top 1.6%.
Is Avecho Biotechnology's FCF Margin % too high?
Avecho Biotechnology's current FCF Margin % is -501.76%. Based on the distribution chart, Avecho Biotechnology ranks #15 out of 949 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers.
How does Avecho Biotechnology's FCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Avecho Biotechnology ranks #15 out of 949 companies for FCF Margin %. This places Avecho Biotechnology in the top 2% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Avecho Biotechnology and its competitors. Avecho Biotechnology's current FCF Margin % is -501.76%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Avecho Biotechnology stock overvalued right now?
Avecho Biotechnology (AVEFF) has a current FCF Margin % of -501.76%. The current FCF Margin % is -501.76%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Avecho Biotechnology (AVEFF), the current FCF Margin % is -501.76% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Avecho Biotechnology Business Description

Other Exchanges OEZ:GermanyAVE:Australia
Address Unit A8, 2A Westall Road, Clayton, Melbourne, VIC, AUS, 3168
Avecho Biotechnology Ltd is a research-based biotechnology company engaged in the development, production, sales, and licensing of products incorporating its patented platform technology Tocopheryl Phosphate Mixture (TPM), for the pharmaceutical, skincare, and animal health and nutrition industries. Its segments include Production, Human Health, and other segments. The Production segment, which is the key revenue driver, manufactures and sells TPM and Vital ET for use in drug delivery and cosmetic formulations. The Human Health segment's portfolio covers the delivery of drugs through gels, injectables, and patches, including the conduct of research and development activities. It focuses on the development of patches, including TPM/Oxymorphone and TPM/Oxycodone.